Evaluating Renal Biomarkers in Diabetic Nephropathy: Significant Variations Across Groups
Keywords:
ESRD, improving, pathophysiology, outcomesAbstract
Diabetic nephropathy (DN) is one of the most serious complications associated with diabetes mellitus (DM) and a leading cause of end-stage renal disease (ESRD) worldwide. DN is characterized by progressive kidney dysfunction, typically manifesting as albuminuria, glomerular hypertrophy, and a gradual decline in the glomerular filtration rate (GFR). Early detection and intervention are crucial to prevent the progression of DN to ESRD, making the study of renal biomarkers an essential aspect of understanding DN's pathophysiology and improving patient outcomes
References
Botirova N. A. DIAGNOSTIC SIGNIFICANCE OF KLOTHO AND CYSTATIN C IN THE EARLY
STAGE OF CHRONIC KIDNEY DISEASE IN TYPE 2 DIABETES MELLITEUS //Proceedings of
International Conference on Scientific Research in Natural and Social Sciences. – 2024. – Т. 3. – №.
– С. 111-113.2. Botirova N. A., Mirahmedova H. T. SIGNIFICANCE OF STANDARD AND NEWLY STUDIED
BIOMARKERS IN THE DIAGNOSIS OF ADVANCED CHRONIC KIDNEY DISEASE AGAINST
THE BACKGROUND OF DIABETIC NEPHROPATHY IN TYPE 2 DIABETES //Western
European Journal of Medicine and Medical Science. – 2023. – Т. 1. – №. 3. – С. 5-10.
Botirova N. A. THE SIGNIFICANCE OF THE KLOTHO PROTEIN AT THE EARLY STAGE OF
DIABETIC NEPHROPATHY //Proceedings of Scientific Conference on Multidisciplinary Studies. –
– Т. 3. – №. 2. – С. 28-29.
Мирахмедова Х. Т., Ботирова Н. А. Кандли диабетнинг 2-типида ривожланган сурункали
буйрак касаллигини эрта ташхислашда Клото хамда цистатин С нинг ахамияти: дис. –
Ташкентская медицинская академия, Ташкент, Узбекистан, 2024.
Мирахмедова Х. Т., Ботирова Н. А. 2-тип кандли диабет билан огриган беморларда диабетик
нефропатиянинг эрта боскичида клото омилининг ахамияти: дис. – Ташкентская медицинская
академия, Ташкент, Узбекистан, 2024.
Мирахмедова, Хилола Тухтасиновна, and Ботирова Нигина. "Actual Problems of Diabetic
Nephropathy, Risk Factors, Stages, Progression, Mechanism, Diagnosis and Management." (2022).
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
User Rights
Under the Creative Commons Attribution-NonCommercial 4.0 International (CC-BY-NC), the author (s) and users are free to share (copy, distribute and transmit the contribution).
Rights of Authors
Authors retain the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. the right to use the substance of the article in future works, including lectures and books,
3. the right to reproduce the article for own purposes, provided the copies are not offered for sale,
4. the right to self-archive the article.
